A. R. Gennery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
A. R. Gennery has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
A J Cant
Institute of Cellular Medicine, University of Newcastle, Newcastle upon Tyne, UK
3 shared publicationsA. J. Cant
Department of Paediatric Immunology Newcastle General Hospital Westgate Road Newcastle upon Tyne NE4 6BE UK E‐mail
2 shared publicationsD Barge
Immunology, Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastle upon Tyne, UK
2 shared publicationsT J Flood
Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, UK
2 shared publicationsA Jackson
Molecular Genetics, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
1 shared publicationJ J O'Sullivan
Department of Paediatric Cardiology, Freeman Hospital, Newcastle upon Tyne
1 shared publication
Latest Publications
- 1 November 2011
- Published by Springer Nature in Pediatric Research
- Vol. 70, 463
Effect of Serotherapy dose on Immunoreconstitution Following Umbilical Cord Stem Cell Transplant for Primary Immunodeficiency
- 1 November 2011
- Published by Springer Nature in Pediatric Research
- Vol. 70, 463
Effect of Serotherapy dose on Immunoreconstitution Following Umbilical Cord Stem Cell Transplant for Primary Immunodeficiency
- 11 December 2002
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 32 (12) , 1677-1678
Development of allergy post-bone marrow transplantation
- 11 December 2002
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 32 (12) , 1677-1678
Development of allergy post-bone marrow transplantation
- Open Access
- 1 June 2002
- Published by BMJ in Archives of Disease in Childhood
- Vol. 86 (6) , 422-425
Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome
Background: Although severe T cell immunodeficiency in DiGeorge anomaly is rare, previous studies of humoral function in these patients have found no antibody abnormalities but have not examined the response to polysaccharide antigens. Isolated cases of autoimmunity have been reported. Several patients with 22q11.2 deletion attending our immunology clinic suffered recurrent sinopulmonary infection or autoimmune phenomena. Aims: To investigate humoral immunodeficiency, particularly pneumococcal polysaccharide antibody deficiency, and autoimmune phenomena in a cohort of patients with 22q11.2 deletion. Methods: A history of severe or recurrent infection and autoimmune symptoms were noted. Lymphocyte subsets, immunoglobulins, IgG subclasses, specific vaccine antibodies, and autoantibodies were measured. Subjects were vaccinated with appropriate antigens as indicated. Results: Of 32 patients identified, 26 (81%) had severe or recurrent infection, of which 13 (50%) had abnormal serum immunoglobulin measurements and 11/20 ≥4 years old (55%) had an abnormal response to pneumococcal polysaccharide. Ten of 30 patients (33%) had autoimmune phenomena; six (20%) were symptomatic. Conclusions: Humoral immunodeficiency is more common than previously recognised in patients with 22q11.2 deletion. Normal T cell function and immunoglobulin levels do not exclude poor specific antibody responses. Patients should be referred for formal immunological assessment of cellular and humoral immune function.
- 1 June 2002
- Published by BMJ in Archives of Disease in Childhood
- Vol. 86 (6) , 422-425
Open AccessAntibody deficiency and autoimmunity in 22q11.2 deletion syndrome
Background: Although severe T cell immunodeficiency in DiGeorge anomaly is rare, previous studies of humoral function in these patients have found no antibody abnormalities but have not examined the response to polysaccharide antigens. Isolated cases of autoimmunity have been reported. Several patients with 22q11.2 deletion attending our immunology clinic suffered recurrent sinopulmonary infection or autoimmune phenomena. Aims: To investigate humoral immunodeficiency, particularly pneumococcal polysaccharide antibody deficiency, and autoimmune phenomena in a cohort of patients with 22q11.2 deletion. Methods: A history of severe or recurrent infection and autoimmune symptoms were noted. Lymphocyte subsets, immunoglobulins, IgG subclasses, specific vaccine antibodies, and autoantibodies were measured. Subjects were vaccinated with appropriate antigens as indicated. Results: Of 32 patients identified, 26 (81%) had severe or recurrent infection, of which 13 (50%) had abnormal serum immunoglobulin measurements and 11/20 ≥4 years old (55%) had an abnormal response to pneumococcal polysaccharide. Ten of 30 patients (33%) had autoimmune phenomena; six (20%) were symptomatic. Conclusions: Humoral immunodeficiency is more common than previously recognised in patients with 22q11.2 deletion. Normal T cell function and immunoglobulin levels do not exclude poor specific antibody responses. Patients should be referred for formal immunological assessment of cellular and humoral immune function.
- Open Access
- 1 March 2001
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (3) , 191-195
Diagnosis of severe combined immunodeficiency
Early diagnosis of severe combined immunodeficiency (SCID) is important to enable prompt referral to a supraregional centre for bone marrow transplantation before the occurrence of end organ damage secondary to infective complications. This review outlines clinical, microbiological, and immunopathological clues that aid the diagnosis of SCID and emphasises the multidisciplinary approach needed to diagnose and treat these infants.
- 1 March 2001
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (3) , 191-195
Open AccessDiagnosis of severe combined immunodeficiency
Early diagnosis of severe combined immunodeficiency (SCID) is important to enable prompt referral to a supraregional centre for bone marrow transplantation before the occurrence of end organ damage secondary to infective complications. This review outlines clinical, microbiological, and immunopathological clues that aid the diagnosis of SCID and emphasises the multidisciplinary approach needed to diagnose and treat these infants.
- 1 July 2000
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 121 (1) , 1-7
Immunodeficiency associated with DNA repair defects
- 1 July 2000
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 121 (1) , 1-7
Immunodeficiency associated with DNA repair defects